SULBACIN

This brand name is authorized in Nigeria.

Active ingredients

The drug SULBACIN contains one active pharmaceutical ingredient (API):

1	Sultamicillin UNII 65DT0ML581 - SULTAMICILLIN
	Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant.
	Read more about Sultamicillin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2376	Tablet	Sulbacin Tablets TAB 375 mg 1 x 10's (in blister)	Tablet	28/01/2021
A4-2388	Powder for injection	Sulbacin 0.75 Injection INJ_PWD 750 mg 1's (in vial)	Powder for Solution for Injection in a vial Each vial contains: Sultamicillin 750 mg equiv. to Ampicillin Sodium Sterile 500 mg, Sulbactam Sodium Sterile 250 mg	28/10/2021
A4-2389	Powder for injection	Sulbacin 1.5 Injection INJ_PWD 1.5 g 1.5 g x 1's (in glass vial)	Powder for Solution for Injection	28/01/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CR04	Sultamicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
Discover more medicines within J01CR04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2376, A4-2388, A4-2389